Literature DB >> 28242072

Active surveillance for carbapenem-resistant Acinetobacter baumannii in a medical intensive care unit: Can it predict and reduce subsequent infections and the use of colistin?

Joon Hwan An1, Yu-Hyoung Kim2, Jeong-Eun Moon2, Jong Hae Jeong2, Soo-Hyun Kim3, Seung-Ji Kang1, Kyung-Hwa Park1, Sook-In Jung1, Hee-Chang Jang4.   

Abstract

BACKGROUND: Infection caused by carbapenem-resistant Acinetobacter baumannii (CRAB) has become a major problem in intensive care units (ICUs), with high incidence and mortality. This prospective study investigated the diagnostic value and influence of active surveillance, followed by isolation and enhanced contact precaution (IECP), on the subsequent CRAB infection and colistin use.
METHODS: The study prospectively enrolled 1,115 patients who were admitted to the medical ICU of Chonnam National University Hwasun Hospital between April 2011 and November 2014. Active surveillance cultures were obtained from the throat or trachea, skin, and urine. IECP was performed beginning April 2013.
RESULTS: Active surveillance detected CRAB in 168 (15%) patients and CRAB infection developed in 70 (6%) patients. Endotracheal tube was independently associated with both CRAB colonization and infection, whereas IECP was inversely associated with both CRAB colonization and infection in multivariate analysis (all P values <.001). The sensitivity, specificity, and positive and negative predictive values of active surveillance for subsequent CRAB infection were 84%, 90%, 47%, and 98%, respectively. The rate of CRAB acquisition, CRAB infection, and the use of colistin were significantly lower during the IECP period compared with the control period (6.5 vs 34.1, 2.6 vs 14.7, and 19.9 vs 65.5 per 1,000 patient-days, respectively; all P <.001).
CONCLUSIONS: Active surveillance has good specificity and negative predictive value for subsequent CRAB infection. Active surveillance followed by IECP was inversely associated with the acquisition of CRAB and subsequent CRAB infection, and was associated with a reduction in colistin use in ICU patients.
Copyright © 2017 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Incidence; Isolation; Precaution

Mesh:

Substances:

Year:  2017        PMID: 28242072     DOI: 10.1016/j.ajic.2017.01.016

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  6 in total

1.  Rapid screening and early precautions for carbapenem-resistant Acinetobacter baumannii carriers decreased nosocomial transmission in hospital settings: a quasi-experimental study.

Authors:  Norihisa Yamamoto; Shigeto Hamaguchi; Yukihiro Akeda; Pitak Santanirand; Narong Chaihongsa; Suntariya Sirichot; Suwichak Chiaranaicharoen; Hideharu Hagiya; Kouji Yamamoto; Anusak Kerdsin; Kazuhisa Okada; Hisao Yoshida; Shigeyuki Hamada; Kazunori Oishi; Kumthorn Malathum; Kazunori Tomono
Journal:  Antimicrob Resist Infect Control       Date:  2019-06-27       Impact factor: 4.887

2.  Intensive Care Unit Relocation and Its Effect on Multidrug-Resistant Respiratory Microorganisms.

Authors:  Hyung-Jun Kim; EuiSeok Jeong; Pyoeng Gyun Choe; Sang-Min Lee; Jinwoo Lee
Journal:  Acute Crit Care       Date:  2018-11-14

3.  The Changes in Epidemiology of Imipenem-Resistant Acinetobacter baumannii Bacteremia in a Pediatric Intensive Care Unit for 17 Years.

Authors:  Dongsub Kim; Haejeong Lee; Joon-Sik Choi; Christina M Croney; Ki-Sup Park; Hyo Jung Park; Joongbum Cho; Sohee Son; Jin Yeong Kim; Soo-Han Choi; Hee Jae Huh; Kwan Soo Ko; Nam Yong Lee; Yae-Jean Kim
Journal:  J Korean Med Sci       Date:  2022-06-20       Impact factor: 5.354

4.  Phage Therapy as a Promising New Treatment for Lung Infection Caused by Carbapenem-Resistant Acinetobacter baumannii in Mice.

Authors:  Yunfen Hua; Tingting Luo; Yiqi Yang; Dong Dong; Rui Wang; Yanjun Wang; Mengsha Xu; Xiaokui Guo; Fupin Hu; Ping He
Journal:  Front Microbiol       Date:  2018-01-09       Impact factor: 5.640

5.  A prospective surveillance study for multidrug-resistant bacteria colonization in hospitalized patients at a Thai University Hospital.

Authors:  Pinyo Rattanaumpawan; Chatiros Choorat; Kanchanaporn Takonkitsakul; Teerawit Tangkoskul; Chakrapong Seenama; Visanu Thamlikitkul
Journal:  Antimicrob Resist Infect Control       Date:  2018-08-20       Impact factor: 4.887

6.  Risk factor for intestinal carriage of carbapenem-resistant Acinetobacter baumannii and the impact on subsequent infection among patients in an intensive care unit: an observational study.

Authors:  Fu Qiao; Wenzhi Huang; Shan Gao; Lin Cai; Shichao Zhu; Li Wei; Yan Kang; Chuanmin Tao; Zhiyong Zong
Journal:  BMJ Open       Date:  2020-09-09       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.